Weber, H http://orcid.org/0000-0002-9421-1292
Richter, J
Straube, B http://orcid.org/0000-0002-9837-0944
Lueken, U
Domschke, K
Schartner, C
Klauke, B
Baumann, C
Pané-Farré, C
Jacob, C P
Scholz, C-J
Zwanzger, P
Lang, T
Fehm, L
Jansen, A
Konrad, C
Fydrich, T
Wittmann, A
Pfleiderer, B
Ströhle, A
Gerlach, A L
Alpers, G W
Arolt, V
Pauli, P
Wittchen, H-U
Kent, L
Hamm, A
Kircher, T
Deckert, J
Article History
Received: 13 April 2015
Revised: 23 June 2015
Accepted: 6 July 2015
First Online: 1 September 2015
Competing interests
: V Arolt is a member of the advisory boards and/or gave presentations for the following companies: Astra-Zeneca, Eli Lilly, Janssen-Organon, Lundbeck, Otsuka, Servier, and Trommsdorff. He also received research grants from Astra-Zeneca, Lundbeck and Servier. He chaired the committee for the ‘Wyeth Research Award Depression and Anxiety’. J Deckert received in the past 3 years honoraria by Janssen, Bristol Myers-Squibb, Wyeth, Lundbeck, Astra-Zeneca and Pfizer and Grant Support by Medice, Lundbeck and Astra-Zeneca. T Kircher received fees for educational programs from Janssen, Eli Lilly, Servier, Lundbeck, Bristol Myers Squibb, Pfitzer and Astra-Zeneca; travel support/sponsorship for congresses from Servier; speaker's honoraria from Janssen; and research grants from Pfizer and Lundbeck. C Konrad received fees for educational programs from Esparma/Aristo Pharma GmbH, Eli Lilly, Servier and MagVenture. A Reif has received research support from PsyNova, and A Reif and K Domschke have received research grants from Astra Zeneca. K Domschke has received honoraria for scientific talks from Pfizer, Lilly and Bristol-Myers Squibb and has been a consultant for Johnson&Johnson. A Ströhle received research funding from the German Federal Ministry of Education and Research, the European Commission (FP6) and Lundbeck and speaker honoraria from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly & Co, Lundbeck, Pfizer, Wyeth and UCB. He was a consultant for Actelion. Educational grants were given by the Stifterverband für die Deutsche Wissenschaft, the Berlin Brandenburgische Akademie der Wissenschaften, the Boehringer Ingelheim Fonds, the Eli Lilly International Foundation, Janssen-Cilag, Pfizer and Eli Lilly. H-U Wittchen has served as a general consultant (non-product related) for Pfizer, Organon, Servier and EssexPharma and has received grant funding for his institution from Sanofi Aventis, Pfizer, Lundbeck, Novatis, Essex Pharma, Servier and Wyeth. These cooperations have no relevance to the work that is covered in the manuscript. The other authors declare no conflict of interest.